Nirmatrelvir/Ritonavir · more major-labeled pairs than Cilostazol

SPL labels Cilostazol + Nirmatrelvir/Ritonavir as minor; Cilostazol 7 / Nirmatrelvir/Ritonavir 33 in that band.

Mechanism on file: Ritonavir prevents the body from clearing cilostazol normally, which leads to higher and potentially unsafe levels of the drug in your system.

FDA SPL severity: Minor

Cilostazol

Full Cilostazol label record

PDE3 Inhibitor (Antiplatelet)

Nirmatrelvir/Ritonavir

Full Nirmatrelvir/Ritonavir label record

Antiviral (Protease Inhibitor Combination)

Cilostazol + Nirmatrelvir/Ritonavir · SPL mechanism field

Ritonavir prevents the body from clearing cilostazol normally, which leads to higher and potentially unsafe levels of the drug in your system.

Minor band excerpt · Cilostazol with Nirmatrelvir/Ritonavir

cilostazol ↑ cilostazol Dosage adjustment of cilostazol is recommended. Refer to the cilostazol product label for more information.

Nirmatrelvir/Ritonavir · 23 major-labeled pairs (vs Cilostazol's 0)

View all Nirmatrelvir/Ritonavir interactions →

FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.